[Clinical trial of Midalgyl in rheumatology].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D011431:Dextropropoxyphene / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006073:Gout / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012457:Salicylamides / Q000627:therapeutic use*; D012585:Sciatica / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D012457:Salicylamides; D010653:Phenylbutazone; D011431:Dextropropoxyphene
Essai clinique du Midalgyl en rhumatologie.